Castle Biosciences, Inc. (CSTL)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 11:25AM EDT. Market open.
| Previous Close | 19.86 |
| Open | 19.07 |
| Bid | 19.01 x 200 |
| Ask | 19.40 x 200 |
| Day's Range | 18.76 - 19.67 |
| 52 Week Range | 9.26 - 26.70 |
| Volume | |
| Avg. Volume | 233,661 |
| Market Cap | 530.224M |
| Beta (5Y Monthly) | 0.92 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024
FRIENDSWOOD, Texas, April 11, 2024--Castle will release its financial results for the first quarter ended March 31, 2024, after the close of market on Thursday, May 2, 2024.
- Business Wire
Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations
FRIENDSWOOD, Texas, April 10, 2024--Castle recognizes the importance of Esophageal Cancer Awareness Month and is providing its support of key programs and initiatives throughout April.
- Business Wire
Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year
FRIENDSWOOD, Texas, April 10, 2024--For the second year in a row, Castle's chief financial officer, Frank Stokes, has been selected as a Top 25 CFO of Houston by TOP CFOs.
© 2024 Yahoo. All rights reserved.